NEXGEL (NXGL) Misses Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts NXGL Hot Sheet
Join SI Premium – FREE
NEXGEL (NASDAQ: NXGL) reported Q3 EPS of ($0.08), $0.07 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $2.93 million versus the consensus estimate of $3.45 million.
For earnings history and earnings-related data on NEXGEL (NXGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zoetis (ZTS) Tops Q3 EPS by 24c; offers guidance
- Amylyx Pharmaceuticals, Inc. (AMLX) Reports In-Line Q3 EPS
- Advanced Drainage Systems (WMS) Tops Q2 EPS by 7c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
